Abstract
BackgroundIn gastric cancer, the HER2 overexpression (6% to 29.5% of gastric cancers) is considered to increase proliferation activity and suppress apoptosis of the cancer cells.1 However, HER2-targeting therapy in gastric...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have